Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1970 Sep;40(1):146P+.

Alprenolol and propranolol in hyperthyroid tachycardia.

P Turner
PMCID: PMC1702707  PMID: 4395079

Full text

PDF
146P

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ablad B., Brogård M., Ek L. Pharmacological properties of H 56-28--a beta-adrenergic receptor antagonist. Acta Pharmacol Toxicol (Copenh) 1967;25:9–40. [PubMed] [Google Scholar]
  2. Johnsson G., Norrby A., Sölvell L. Potency and time effect relationship in man of propranolol and H 56-28. I. Comparative studies after intravenous administration. II. Studies on the ratio of equipotent oral and intravenous doses. Acta Pharmacol Toxicol (Copenh) 1967;25:95–105. doi: 10.1111/j.1600-0773.1967.tb03000.x. [DOI] [PubMed] [Google Scholar]
  3. Kofi Ekue J. M., Lowe D. C., Shanks R. G. Comparison of the effects of propranolol and MJ 1999 on cardiac beta-adrenoceptors in man. Br J Pharmacol. 1970 May;38(3):546–553. doi: 10.1111/j.1476-5381.1970.tb10596.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Turner P., Hill R. C. A comparison of three beta-adrenergic receptor-blocking drugs in thyrotoxic tachycardia. J Clin Pharmacol J New Drugs. 1968 Jul-Aug;8(4):268–271. doi: 10.1002/j.1552-4604.1968.tb00104.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES